Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

DOP048: PROFILE trial: Predicting outcomes for Crohn’s Disease using a molecular biomarkerECCO'17 Barcelona
Year: 2017
Authors: Noor N.
Natural history, Genetics, T cell
Files: 1
DOP051: Serological biomarkers of tissue turnover can early identify responders to infliximab in Crohn’s DiseaseECCO'17 Barcelona
Year: 2017
Authors: van Haaften W.
Crohn's disease, Inflixmab, Fibroblast, Fibrosis, Mesenchymal cell
Files: 1
DOP055: Results of the Fifth Scientific Workshop of the ECCO (II): Clinical aspects of perianal fistulising Crohn’s Disease - The unmet needsECCO'17 Barcelona
Year: 2017
Authors: Gecse K.
MDT, Perianal disease, Perianal fistulae, Abscess
Files: 1
DOP056: Pathophysiology of perianal Fistulising DiseaseECCO'17 Barcelona
Year: 2017
Authors: Scharl M.
Perianal disease
Files: 1
DOP057: Perianal pediatric Crohn's Disease is associated with a distinct phenotype and greater inflammatory burdenECCO'17 Barcelona
Year: 2017
Authors: Assa A.
Crohn's disease, Disease activity Indices, Perianal fistulae, Perianal disease
Files: 1
DOP058: Does biologic therapy increase the risk for fistula-associated mucinous adenocarcinoma in long standing perianal Crohn’s Disease?ECCO'17 Barcelona
Year: 2017
Authors: Laureti S.
Perianal fistulae, Perianal disease, Colorectal cancer
Files: 1
DOP059: New human gut xenograft mouse model for intestinal fistulasECCO'17 Barcelona
Year: 2017
Authors: Bruckner R.
Perianal fistulae, Enteroenteric fistula, Immunology, Mouse Model
Files: 1
DOP060: Real-world treatment pathway visualizations show low use of biologic therapies in Crohn’s Disease and Ulcerative Colitis in the United StatesECCO'17 Barcelona
Year: 2017
Authors: Siegel C.
Anti-TNF agents, Corticosteriods, Patient choice, Thiopurines (AZA / MP)
Files: 1
DOP063: Serial tuberculin skin test improves the detection of latent tuberculosis infection in Inflammatory Bowel Disease patientsECCO'17 Barcelona
Year: 2017
Authors: Taxonera C.
Crohn's disease, Ulcerative colitis, Anti-TNF agents, Thiopurines (AZA / MP), Tuberculosis
Files: 1
DOP066: Strict surveillance colonoscopy should be performed for the Ulcerative Colitis patients who underwent ileorectal anastomosisECCO'17 Barcelona
Year: 2017
Authors: Anzai H.
Colonoscopy, Dysplasia, UC colorectal cancer surveillance
Files: 1
DOP067: Risk of malignant and non-malignant complications of the rectal stump in patients with Inflammatory Bowel DiseaseECCO'17 Barcelona
Year: 2017
Authors: Bogaerts J.
Post-operative IBD, Dysplasia, UC colorectal cancer surveillance
Files: 1
DOP069: Natural history of dysplasia and colorectal cancer in IBD patients in Belgium tertiary care centersECCO'17 Barcelona
Year: 2017
Authors: Cremer A.
Natural history, Dysplasia, UC colorectal cancer surveillance
Files: 1
DOP070: Endoscopic response to induction therapy with TNF inhibitors is the best predictor of long term mucosal healing in Crohn’s DiseaseECCO'17 Barcelona
Year: 2017
Authors: Alfaro I.
Crohn's disease, Disease activity indices, Adalimumab, Infliximab, Colonoscopy
Files: 1